A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.

Pradhan, Pallab; Leleux, Jardin; Liu, Jiaying; Roy, Krishnendu

Pradhan, Pallab; Leleux, Jardin; Liu, Jiaying; Roy, Krishnendu.

JCI Insight ; 2(22)2017 11 16.

Article in En | MEDLINE | ID: mdl-29202455

Subject(s)

Lymphoma, B-Cell/immunology; Lymphoma, B-Cell/prevention & control; Vaccines/immunology; Vaccines/therapeutic use; Animals; Antineoplastic Agents/immunology; Biomarkers; Cell Line, Tumor; Galactosylceramides; Humans; Immunity, Humoral; Immunotherapy; Lymph Nodes/pathology; Lymphoma, B-Cell/pathology; Lymphoma, Non-Hodgkin/prevention & control; Mice; Mice, Inbred BALB C; Natural Killer T-Cells/immunology; Survival Rate; T-Lymphocytes/immunology; Th1 Cells

Key words

Cancer immunotherapy; Immunology; Lymphomas; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Vaccines / Lymphoma, B-Cell Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: JCI Insight Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google